Cholinergic Muscarinic Antagonist [EPC]

Cholinergic Muscarinic Antagonist [EPC] was reported 39246 times

These side effects are most commonly reported by patients taking drugs of the Cholinergic Muscarinic Antagonist [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 4640
1 FATIGUE 2139
2 OFF LABEL USE 1902
3 FALL 1788
4 NAUSEA 1782
5 DIARRHOEA 1725
6 PAIN 1523
7 DEATH 1506
8 DIZZINESS 1367
9 HEADACHE 1270
10 DYSPNOEA 1225
11 URINARY TRACT INFECTION 1178
12 ASTHENIA 1154
13 PRURITUS 1138
14 VOMITING 1089
15 CONSTIPATION 1039
16 RASH 1003
17 APPLICATION SITE ERYTHEMA 932
18 MALAISE 912
19 PNEUMONIA 870
20 HYPOTENSION 859
21 PRODUCT ADHESION ISSUE 844
22 GAIT DISTURBANCE 833
23 CONDITION AGGRAVATED 820
24 ERYTHEMA 810
25 PYREXIA 801
26 WEIGHT DECREASED 746
27 ARTHRALGIA 743
28 DRY MOUTH 740
29 PAIN IN EXTREMITY 697
30 ANXIETY 692
31 BACK PAIN 660
32 SOMNOLENCE 659
33 CONFUSIONAL STATE 653
34 ACUTE KIDNEY INJURY 650
35 INSOMNIA 643
36 DRUG EFFECT DECREASED 640
37 ABDOMINAL PAIN 632
38 DEPRESSION 631
39 HYPERTENSION 631
40 CHRONIC KIDNEY DISEASE 623
41 RENAL FAILURE 621
42 APPLICATION SITE PRURITUS 619
43 DRUG INTERACTION 595
44 BALANCE DISORDER 566
45 DECREASED APPETITE 566
46 COUGH 547
47 PRODUCT QUALITY ISSUE 541
48 TOXICITY TO VARIOUS AGENTS 530
49 MUSCULAR WEAKNESS 504
50 ANAEMIA 498
51 MUSCLE SPASMS 497
52 FEELING ABNORMAL 494
53 BRADYCARDIA 486
54 MEMORY IMPAIRMENT 472
55 CHEST PAIN 471
56 PRODUCT USE ISSUE 456
57 TREMOR 450
58 DEHYDRATION 447
59 PRODUCT DOSE OMISSION ISSUE 442
60 HYPOAESTHESIA 436
61 ALOPECIA 432
62 VISION BLURRED 424
63 ABDOMINAL PAIN UPPER 419
64 NEUROPATHY PERIPHERAL 419
65 CARDIAC ARREST 417
66 WEIGHT INCREASED 412
67 MULTIPLE SCLEROSIS RELAPSE 411
68 PERIPHERAL SWELLING 411
69 PARAESTHESIA 403
70 COVID-19 379
71 POLLAKIURIA 377
72 URINARY INCONTINENCE 376
73 MOBILITY DECREASED 370
74 BLOOD PRESSURE INCREASED 369
75 ATRIAL FIBRILLATION 360
76 TACHYCARDIA 360
77 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 358
78 PRODUCT USE IN UNAPPROVED INDICATION 353
79 SEPSIS 353
80 APPLICATION SITE RASH 351
81 HYPERSENSITIVITY 351
82 OVERDOSE 351
83 CEREBROVASCULAR ACCIDENT 347
84 DRUG HYPERSENSITIVITY 347
85 INFECTION 344
86 CONTUSION 336
87 THERAPY CESSATION 336
88 DYSPHAGIA 334
89 OEDEMA PERIPHERAL 333
90 LOSS OF CONSCIOUSNESS 332
91 ABDOMINAL DISCOMFORT 330
92 VISUAL IMPAIRMENT 327
93 HOSPITALISATION 324
94 HYPERHIDROSIS 315
95 SEIZURE 310
96 DYSPEPSIA 301
97 DRUG DOSE OMISSION 299
98 THERAPY INTERRUPTED 298
99 HALLUCINATION 297
100 SYNCOPE 293
101 URINARY RETENTION 291
102 MULTIPLE SCLEROSIS 280
103 NASOPHARYNGITIS 279
104 NEUTROPENIA 278
105 DISEASE PROGRESSION 272
106 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 272
107 MYALGIA 270
108 FLUSHING 267
109 INCORRECT DOSE ADMINISTERED 265
110 HAEMOGLOBIN DECREASED 262
111 URTICARIA 259
112 APPLICATION SITE PAIN 258
113 WHITE BLOOD CELL COUNT DECREASED 258
114 CHILLS 257
115 GENERAL PHYSICAL HEALTH DETERIORATION 254
116 MYOCARDIAL INFARCTION 254
117 GASTROOESOPHAGEAL REFLUX DISEASE 252
118 RESPIRATORY FAILURE 251
119 DYSARTHRIA 249
120 FEBRILE NEUTROPENIA 249
121 PULMONARY EMBOLISM 249
122 BURNING SENSATION 248
123 COMPLETED SUICIDE 241
124 INJECTION SITE PAIN 241
125 ARTHRITIS 238
126 BLOOD GLUCOSE INCREASED 235
127 OXYGEN SATURATION DECREASED 231
128 GASTROINTESTINAL HAEMORRHAGE 228
129 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 225
130 INFLUENZA 225
131 JOINT SWELLING 224
132 MUSCULOSKELETAL STIFFNESS 224
133 ABDOMINAL DISTENSION 223
134 HEART RATE INCREASED 223
135 DYSURIA 222
136 SKIN IRRITATION 222
137 CARDIAC FAILURE CONGESTIVE 220
138 AGITATION 219
139 HOT FLUSH 219
140 COGNITIVE DISORDER 218
141 DELIRIUM 217
142 NEPHROLITHIASIS 215
143 CHEST DISCOMFORT 214
144 CYSTITIS 212
145 AMNESIA 209
146 HAEMATOCHEZIA 209
147 INFUSION RELATED REACTION 209
148 BRONCHITIS 208
149 APPLICATION SITE IRRITATION 206
150 THROMBOCYTOPENIA 205
151 RASH ERYTHEMATOUS 201
152 DRY SKIN 198
153 PALPITATIONS 197
154 UNEVALUABLE EVENT 197
155 BLOOD PRESSURE DECREASED 194
156 DRUG ADMINISTERED AT INAPPROPRIATE SITE 194
157 OROPHARYNGEAL PAIN 194
158 SINUSITIS 193
159 EPISTAXIS 190
160 ASTHMA 188
161 OSTEOARTHRITIS 186
162 MENTAL STATUS CHANGES 183
163 PLATELET COUNT DECREASED 183
164 DEPRESSED LEVEL OF CONSCIOUSNESS 181
165 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 180
166 THROMBOSIS 180
167 EMOTIONAL DISTRESS 179
168 PRODUCT DOSE OMISSION 177
169 RENAL IMPAIRMENT 176
170 SWELLING 176
171 RENAL INJURY 175
172 CATARACT 174
173 DYSPHONIA 174
174 SPEECH DISORDER 174
175 RASH PRURITIC 173
176 RECTAL HAEMORRHAGE 173
177 HYPONATRAEMIA 172
178 STRESS 171
179 CARDIAC DISORDER 169
180 INTENTIONAL PRODUCT MISUSE 169
181 LETHARGY 168
182 MIGRAINE 168
183 PLEURAL EFFUSION 168
184 CARDIO-RESPIRATORY ARREST 167
185 SEDATION 167
186 DEEP VEIN THROMBOSIS 166
187 INJURY 166
188 RHEUMATOID ARTHRITIS 166
189 SLEEP DISORDER 166
190 CARDIAC FAILURE 165
191 VERTIGO 164
192 SURGERY 163
193 COMA 162
194 PSORIASIS 162
195 END STAGE RENAL DISEASE 159
196 DISCOMFORT 158
197 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 157
198 PULMONARY OEDEMA 156
199 CELLULITIS 155
200 HYPOKALAEMIA 154
201 UNRESPONSIVE TO STIMULI 153
202 RENAL FAILURE ACUTE 152
203 BLISTER 149
204 INFLUENZA LIKE ILLNESS 149
205 DISORIENTATION 147
206 DYSKINESIA 147
207 HEART RATE DECREASED 147
208 ADVERSE DRUG REACTION 146
209 COLITIS 145
210 DIABETES MELLITUS 145
211 DRY EYE 144
212 HAEMORRHAGE 144
213 INCORRECT DRUG ADMINISTRATION DURATION 144
214 MACULAR DEGENERATION 143
215 HERPES ZOSTER 142
216 HYPERKALAEMIA 142
217 ANAPHYLACTIC REACTION 141
218 DRUG INTOLERANCE 141
219 DRUG EFFECT INCOMPLETE 140
220 ORTHOSTATIC HYPOTENSION 140
221 HYPOXIA 139
222 BLOOD CREATININE INCREASED 138
223 HAEMATURIA 138
224 CONVULSION 137
225 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 137
226 INTENTIONAL OVERDOSE 137
227 GASTROINTESTINAL DISORDER 136
228 INTESTINAL OBSTRUCTION 135
229 MICTURITION URGENCY 135
230 OSTEOPOROSIS 135
231 ILLNESS 134
232 TREATMENT FAILURE 134
233 ARTHROPATHY 133
234 BLADDER DISORDER 133
235 STOMATITIS 133
236 INTENTIONAL PRODUCT USE ISSUE 132
237 FEELING HOT 131
238 HALLUCINATION, VISUAL 131
239 DEMENTIA 130
240 ADVERSE EVENT 129
241 ILL-DEFINED DISORDER 129
242 SKIN DISCOLOURATION 128
243 ANTICHOLINERGIC SYNDROME 127
244 RHABDOMYOLYSIS 127
245 RHINORRHOEA 127
246 THERAPEUTIC RESPONSE UNEXPECTED 127
247 DYSGEUSIA 126
248 WRONG TECHNIQUE IN DRUG USAGE PROCESS 126
249 EXPIRED PRODUCT ADMINISTERED 125
250 EYE PAIN 125
251 FLATULENCE 125
252 OEDEMA 125
253 THERAPY NON-RESPONDER 125
254 RESPIRATORY ARREST 124
255 MALIGNANT NEOPLASM PROGRESSION 122
256 HIP FRACTURE 121
257 NOCTURIA 121
258 SKIN EXFOLIATION 121
259 ROAD TRAFFIC ACCIDENT 119
260 SALIVARY HYPERSECRETION 119
261 HEAD INJURY 118
262 SEPTIC SHOCK 118
263 FLUID RETENTION 117
264 NECK PAIN 117
265 SUICIDAL IDEATION 117
266 VENTRICULAR TACHYCARDIA 117
267 ALANINE AMINOTRANSFERASE INCREASED 116
268 DYSSTASIA 116
269 MENTAL DISORDER 116
270 ACUTE RESPIRATORY FAILURE 115
271 DYSPNOEA EXERTIONAL 115
272 PSYCHOTIC DISORDER 115
273 MOUTH ULCERATION 114
274 NEPHROGENIC ANAEMIA 114
275 ORAL CANDIDIASIS 113
276 ARRHYTHMIA 112
277 DRUG ABUSE 112
278 INCONTINENCE 112
279 ORAL PAIN 112
280 CARDIOGENIC SHOCK 111
281 DISTURBANCE IN ATTENTION 110
282 ELECTROCARDIOGRAM QT PROLONGED 110
283 GAIT INABILITY 110
284 HYPOGLYCAEMIA 110
285 PRODUCT PACKAGING ISSUE 110
286 NEURALGIA 109
287 PNEUMONIA ASPIRATION 109
288 PRODUCTIVE COUGH 109
289 ANHEDONIA 108
290 ENCEPHALOPATHY 108
291 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 108
292 NERVOUSNESS 108
293 MATERNAL EXPOSURE DURING PREGNANCY 107
294 PANCYTOPENIA 107
295 SWELLING FACE 107
296 LIMB DISCOMFORT 106
297 INJECTION SITE ERYTHEMA 105
298 NASAL CONGESTION 105
299 TREATMENT NONCOMPLIANCE 105
300 HYPERTONIC BLADDER 104
301 MUSCULOSKELETAL PAIN 104
302 PARAESTHESIA ORAL 104
303 DEPRESSED MOOD 103
304 MOVEMENT DISORDER 103
305 STRESS CARDIOMYOPATHY 103
306 BONE PAIN 102
307 COLITIS ULCERATIVE 102
308 FREQUENT BOWEL MOVEMENTS 102
309 HEPATIC ENZYME INCREASED 102
310 MUSCLE SPASTICITY 102
311 UPPER RESPIRATORY TRACT INFECTION 102
312 INFLAMMATION 101
313 METABOLIC ACIDOSIS 101
314 SLEEP APNOEA SYNDROME 101
315 BLINDNESS 100
316 KIDNEY INFECTION 100
317 APHASIA 99
318 APPLICATION SITE BURN 99
319 ECONOMIC PROBLEM 99
320 THROAT IRRITATION 99
321 UNDERDOSE 99
322 ASPARTATE AMINOTRANSFERASE INCREASED 98
323 DEVICE ISSUE 98
324 NO ADVERSE EVENT 97
325 WHEEZING 97
326 RASH MACULAR 96
327 MUCOSAL INFLAMMATION 95
328 VENTRICULAR FIBRILLATION 95
329 BLOOD POTASSIUM DECREASED 94
330 BLOOD URINE PRESENT 94
331 HYPERTHERMIA 94
332 RENAL DISORDER 94
333 BLOOD CHOLESTEROL INCREASED 93
334 SINUS BRADYCARDIA 93
335 BLOOD CALCIUM DECREASED 92
336 HYPERSOMNIA 92
337 INTERVERTEBRAL DISC PROTRUSION 92
338 POST PROCEDURAL COMPLICATION 92
339 PROCEDURAL PAIN 92
340 SKIN BURNING SENSATION 92
341 WHITE BLOOD CELL COUNT INCREASED 92
342 PARKINSON^S DISEASE 91
343 BLOOD CREATINE PHOSPHOKINASE INCREASED 90
344 BLOOD PRESSURE FLUCTUATION 90
345 HYPOPHAGIA 90
346 LUNG DISORDER 89
347 RED BLOOD CELL COUNT DECREASED 89
348 FUNGAL INFECTION 88
349 HAEMATOCRIT DECREASED 88
350 LABORATORY TEST ABNORMAL 88
351 LOWER RESPIRATORY TRACT INFECTION 88
352 MYDRIASIS 88
353 ANKLE FRACTURE 87
354 PSORIATIC ARTHROPATHY 87
355 CHROMATURIA 86
356 FOETAL EXPOSURE DURING PREGNANCY 86
357 SUICIDE ATTEMPT 86
358 ABASIA 85
359 ACUTE MYOCARDIAL INFARCTION 85
360 CORONARY ARTERY DISEASE 84
361 EMOTIONAL DISORDER 84
362 EYE DISORDER 84
363 TRANSIENT ISCHAEMIC ATTACK 84
364 ABNORMAL BEHAVIOUR 83
365 ACCIDENTAL OVERDOSE 83
366 LEUKOPENIA 83
367 SINUS TACHYCARDIA 83
368 TINNITUS 82
369 ANAPHYLACTIC SHOCK 81
370 APPLICATION SITE DISCOLOURATION 81
371 CROHN^S DISEASE 81
372 DIPLOPIA 81
373 HYPOTHYROIDISM 81
374 RADICULOPATHY 81
375 RESTLESSNESS 81
376 AGGRESSION 79
377 FOOT FRACTURE 79
378 IRRITABILITY 79
379 NEOPLASM MALIGNANT 79
380 PRODUCT SUBSTITUTION ISSUE 79
381 FEAR 78
382 HYPOACUSIS 78
383 SWOLLEN TONGUE 78
384 EYE IRRITATION 77
385 LIVER FUNCTION TEST ABNORMAL 77
386 DRUG EFFECT DELAYED 76
387 INJECTION SITE REACTION 76
388 LYMPHOCYTE COUNT DECREASED 76
389 VAGINAL DISCHARGE 76
390 CEREBRAL HAEMORRHAGE 75
391 CHOLELITHIASIS 75
392 LIP SWELLING 75
393 STAPHYLOCOCCAL INFECTION 75
394 VISUAL ACUITY REDUCED 75
395 HAEMATEMESIS 74
396 MITRAL VALVE INCOMPETENCE 74
397 PANCREATITIS 74
398 PULMONARY HYPERTENSION 74
399 SHOCK 74
400 VENTRICULAR EXTRASYSTOLES 74
401 MEDICATION ERROR 73
402 RESPIRATORY DISTRESS 73
403 THERAPEUTIC RESPONSE DECREASED 73
404 DERMATITIS CONTACT 72
405 UPPER GASTROINTESTINAL HAEMORRHAGE 72
406 CARDIOMYOPATHY 71
407 FEMALE GENITAL TRACT FISTULA 71
408 MUSCLE TWITCHING 71
409 PRODUCT CLOSURE REMOVAL DIFFICULT 71
410 UPPER LIMB FRACTURE 71
411 DRUG ADMINISTRATION ERROR 70
412 HYPERGLYCAEMIA 70
413 LIMB INJURY 70
414 OSTEOPENIA 70
415 RESPIRATORY DISORDER 70
416 BLOOD PRESSURE SYSTOLIC INCREASED 69
417 GENERALISED TONIC-CLONIC SEIZURE 69
418 INTERNATIONAL NORMALISED RATIO INCREASED 69
419 OCULAR HYPERAEMIA 69
420 PROCTITIS 69
421 SEDATION COMPLICATION 69
422 ANGINA PECTORIS 68
423 BLOOD GLUCOSE DECREASED 68
424 CARDIOMEGALY 68
425 CHRONIC SINUSITIS 68
426 DEVICE MALFUNCTION 68
427 GASTRITIS 68
428 HEMIPARESIS 68
429 RENAL TUBULAR NECROSIS 68
430 VAGINAL FLATULENCE 68
431 ANGIOEDEMA 67
432 EAR PAIN 67
433 CREATININE RENAL CLEARANCE DECREASED 66
434 GLAUCOMA 66
435 IMPAIRED GASTRIC EMPTYING 66
436 MULTI-ORGAN FAILURE 66
437 PANIC ATTACK 66
438 APNOEA 65
439 INJECTION SITE HAEMORRHAGE 65
440 PARANOIA 65
441 TOOTH DISORDER 65
442 DECUBITUS ULCER 64
443 DRUG TOXICITY 64
444 GASTRIC DISORDER 64
445 HEART RATE IRREGULAR 64
446 INJECTION SITE BRUISING 64
447 INJECTION SITE PRURITUS 64
448 INTENTIONAL DOSE OMISSION 64
449 PAIN IN JAW 64
450 RESPIRATORY DEPRESSION 64
451 RESTLESS LEGS SYNDROME 64
452 URINE ODOUR ABNORMAL 64
453 WITHDRAWAL SYNDROME 64
454 ACNE 63
455 ATAXIA 63
456 C-REACTIVE PROTEIN INCREASED 63
457 HAEMOPTYSIS 63
458 HAEMORRHOIDS 63
459 KNEE ARTHROPLASTY 63
460 LOCALISED INFECTION 63
461 MENTAL IMPAIRMENT 63
462 MUSCLE RIGIDITY 63
463 RIB FRACTURE 63
464 SKIN DISORDER 63
465 SKIN ULCER 63
466 THERAPEUTIC PRODUCT EFFECT DECREASED 63
467 TUBULOINTERSTITIAL NEPHRITIS 63
468 DELUSION 62
469 JOINT INJURY 62
470 PRODUCT DOSE OMISSION IN ERROR 62
471 UROSEPSIS 62
472 WOUND 62
473 BLADDER SPASM 61
474 BLOOD SODIUM DECREASED 61
475 EATING DISORDER 61
476 HAEMATOMA 61
477 MYOCARDIAL ISCHAEMIA 61
478 VIRAL INFECTION 61
479 CENTRAL NERVOUS SYSTEM LESION 60
480 CLOSTRIDIUM DIFFICILE INFECTION 60
481 IMPAIRED HEALING 60
482 IRRITABLE BOWEL SYNDROME 60
483 LACTIC ACIDOSIS 60
484 MYOCARDITIS 60
485 NERVOUS SYSTEM DISORDER 60
486 NIGHTMARE 60
487 PRURITUS GENERALISED 60
488 APLASTIC ANAEMIA 59
489 BLOOD ALKALINE PHOSPHATASE INCREASED 59
490 BODY HEIGHT DECREASED 59
491 CEREBRAL INFARCTION 59
492 CRYING 59
493 HALLUCINATION, AUDITORY 59
494 INJECTION SITE SWELLING 59
495 SINUS DISORDER 59
496 DIVERTICULITIS 58
497 LOWER LIMB FRACTURE 58
498 MUSCULOSKELETAL DISORDER 58
499 NEUTROPHIL COUNT DECREASED 58
500 PRESYNCOPE 58
501 ATELECTASIS 57
502 BREAST CANCER 57
503 CIRCULATORY COLLAPSE 57
504 DISEASE RECURRENCE 57
505 EXPOSURE DURING PREGNANCY 57
506 LEUKOCYTOSIS 57
507 DRUG DEPENDENCE 56
508 EXTRAPYRAMIDAL DISORDER 56
509 FEELING COLD 56
510 JAUNDICE 56
511 PARALYSIS 56
512 SKIN LESION 56
513 VAGINAL HAEMORRHAGE 56
514 VITAMIN D DEFICIENCY 56
515 WALKING AID USER 56
516 BLOOD UREA INCREASED 55
517 DRUG WITHDRAWAL SYNDROME 55
518 POOR QUALITY SLEEP 55
519 PULSELESS ELECTRICAL ACTIVITY 55
520 SCAR 55
521 EPILEPSY 54
522 HYPERPARATHYROIDISM SECONDARY 54
523 PERIPHERAL COLDNESS 54
524 THIRST 54
525 ABNORMAL DREAMS 53
526 ALTERED STATE OF CONSCIOUSNESS 53
527 BLOOD PRESSURE ABNORMAL 53
528 FEMUR FRACTURE 53
529 FIBROMYALGIA 53
530 HAEMODYNAMIC INSTABILITY 53
531 HYPOKINESIA 53
532 INTRAOCULAR PRESSURE INCREASED 53
533 LACERATION 53
534 MUSCLE TIGHTNESS 53
535 OSTEOMYELITIS 53
536 ROTATOR CUFF SYNDROME 53
537 SPINAL OSTEOARTHRITIS 53
538 CHOKING 52
539 DRUG LEVEL INCREASED 52
540 ILEUS 52
541 LYMPHADENOPATHY 52
542 RENAL FUNCTION TEST ABNORMAL 52
543 SCHIZOPHRENIA 52
544 CLOSTRIDIUM DIFFICILE COLITIS 51
545 NIGHT SWEATS 51
546 PERICARDIAL EFFUSION 51
547 WRIST FRACTURE 51
548 ANGER 50
549 APPLICATION SITE VESICLES 50
550 EXOSTOSIS 50
551 EYE SWELLING 50
552 GLYCOSYLATED HAEMOGLOBIN INCREASED 50
553 LUNG NEOPLASM MALIGNANT 50
554 SCIATICA 50
555 TARDIVE DYSKINESIA 50
556 THROAT TIGHTNESS 50
557 TYPE 2 DIABETES MELLITUS 50
558 ASPIRATION 49
559 ATRIOVENTRICULAR BLOCK COMPLETE 49
560 BLINDNESS UNILATERAL 49
561 BLOOD TRIGLYCERIDES INCREASED 49
562 BODY TEMPERATURE INCREASED 49
563 BONE DISORDER 49
564 PNEUMONITIS 49
565 PRODUCT PHYSICAL ISSUE 49
566 ASCITES 48
567 COAGULOPATHY 48
568 COORDINATION ABNORMAL 48
569 HEPATIC STEATOSIS 48
570 HIATUS HERNIA 48
571 HYPOCALCAEMIA 48
572 MELAENA 48
573 PRODUCT STORAGE ERROR 48
574 SPINAL OPERATION 48
575 TEMPERATURE INTOLERANCE 48
576 TRICUSPID VALVE INCOMPETENCE 48
577 ATRIOVENTRICULAR BLOCK FIRST DEGREE 47
578 BIPOLAR DISORDER 47
579 BRASH SYNDROME 47
580 GAMMA-GLUTAMYLTRANSFERASE INCREASED 47
581 GASTROENTERITIS 47
582 PLASMA CELL MYELOMA 47
583 PNEUMOTHORAX 47
584 PULMONARY MASS 47
585 RESPIRATORY TRACT INFECTION 47
586 ABDOMINAL PAIN LOWER 46
587 BRONCHOSPASM 46
588 CYANOSIS 46
589 ECZEMA 46
590 FEEDING DISORDER 46
591 FLANK PAIN 46
592 GLOSSODYNIA 46
593 HYPOAESTHESIA ORAL 46
594 INJECTION SITE MASS 46
595 JOINT STIFFNESS 46
596 MUSCULOSKELETAL CHEST PAIN 46
597 MUSCULOSKELETAL DISCOMFORT 46
598 PALLOR 46
599 PERONEAL NERVE PALSY 46
600 PHOTOPHOBIA 46
601 PRESCRIBED UNDERDOSE 46
602 PULSE ABSENT 46
603 SENSORY DISTURBANCE 46
604 SMALL INTESTINAL OBSTRUCTION 46
605 TACHYPNOEA 46
606 TOOTHACHE 46
607 APHONIA 45
608 GLOMERULAR FILTRATION RATE DECREASED 45
609 HIP ARTHROPLASTY 45
610 HOSPICE CARE 45
611 HYPOVOLAEMIA 45
612 RETCHING 45
613 SUBDURAL HAEMATOMA 45
614 TASTE DISORDER 45
615 ANAL INCONTINENCE 44
616 BLADDER PAIN 44
617 EAR INFECTION 44
618 LIGAMENT SPRAIN 44
619 MOTOR DYSFUNCTION 44
620 NEEDLE ISSUE 44
621 OESOPHAGITIS 44
622 POOR VENOUS ACCESS 44
623 PRODUCT ADMINISTRATION ERROR 44
624 PROTEINURIA 44
625 PULMONARY FIBROSIS 44
626 RASH GENERALISED 44
627 RASH PAPULAR 44
628 REBOUND ACID HYPERSECRETION 44
629 SKIN REACTION 44
630 TROPONIN INCREASED 44
631 AGEUSIA 43
632 APPLICATION SITE DISCOMFORT 43
633 ATRIOVENTRICULAR BLOCK 43
634 FAECALOMA 43
635 FOOT DEFORMITY 43
636 FRACTURE 43
637 HEPATIC FAILURE 43
638 HYPOMAGNESAEMIA 43
639 INTERVERTEBRAL DISC DEGENERATION 43
640 MIDDLE INSOMNIA 43
641 NEUROGENIC BLADDER 43
642 PROSTATE CANCER 43
643 SKIN CANCER 43
644 SPINAL FRACTURE 43
645 SUPRAVENTRICULAR TACHYCARDIA 43
646 TENDON DISORDER 43
647 THERAPEUTIC RESPONSE SHORTENED 43
648 URINE ABNORMALITY 43
649 URINE ANALYSIS ABNORMAL 43
650 ACTIVITIES OF DAILY LIVING IMPAIRED 42
651 BACK DISORDER 42
652 BACTERIAL INFECTION 42
653 BRAIN FOG 42
654 CARPAL TUNNEL SYNDROME 42
655 DRUG PRESCRIBING ERROR 42
656 ERUCTATION 42
657 LIVER DISORDER 42
658 MULTIPLE ORGAN DYSFUNCTION SYNDROME 42
659 OBESITY 42
660 PULMONARY CONGESTION 42
661 RETINAL DETACHMENT 42
662 UVEITIS 42
663 APPLICATION SITE SWELLING 41
664 BLOOD POTASSIUM INCREASED 41
665 DEVICE DISLOCATION 41
666 DRY THROAT 41
667 EJECTION FRACTION DECREASED 41
668 LOCAL SWELLING 41
669 MACULOPATHY 41
670 NEUTROPHIL COUNT INCREASED 41
671 PSYCHOMOTOR HYPERACTIVITY 41
672 SEROTONIN SYNDROME 41
673 CATATONIA 40
674 DEAFNESS 40
675 DIVERTICULUM 40
676 DYSTONIA 40
677 EYE PRURITUS 40
678 FEELING JITTERY 40
679 HYPERCALCAEMIA 40
680 HYPERLIPIDAEMIA 40
681 LEFT VENTRICULAR HYPERTROPHY 40
682 LYMPHOPENIA 40
683 ORAL HERPES 40
684 THYROID DISORDER 40
685 CREATININE RENAL CLEARANCE INCREASED 39
686 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 39
687 ENDOPHTHALMITIS 39
688 FAECAL INCONTINENCE 39
689 FAECES DISCOLOURED 39
690 FULL BLOOD COUNT DECREASED 39
691 HYDRONEPHROSIS 39
692 LEFT VENTRICULAR DYSFUNCTION 39
693 LIVER INJURY 39
694 MOOD ALTERED 39
695 MULTIPLE INJURIES 39
696 NEUROLEPTIC MALIGNANT SYNDROME 39
697 PRE-EXISTING CONDITION IMPROVED 39
698 PREMATURE BABY 39
699 BLOOD BILIRUBIN INCREASED 38
700 BLOOD IRON DECREASED 38
701 BODY TEMPERATURE DECREASED 38
702 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 38
703 CONJUNCTIVITIS 38
704 GINGIVAL BLEEDING 38
705 HYPOTHERMIA 38
706 PRODUCT USE COMPLAINT 38
707 RESPIRATORY TRACT CONGESTION 38
708 STATUS EPILEPTICUS 38
709 ACCIDENT 37
710 ACUTE RESPIRATORY DISTRESS SYNDROME 37
711 BASAL CELL CARCINOMA 37
712 BEDRIDDEN 37
713 BUNDLE BRANCH BLOCK RIGHT 37
714 CORONARY ARTERY OCCLUSION 37
715 DENTAL CARIES 37
716 DIABETES MELLITUS INADEQUATE CONTROL 37
717 ELECTROCARDIOGRAM ABNORMAL 37
718 HAIR TEXTURE ABNORMAL 37
719 HYPERTHERMIA MALIGNANT 37
720 MULTIPLE DRUG THERAPY 37
721 MYOCLONUS 37
722 RENAL CYST 37
723 TOOTH FRACTURE 37
724 ABSCESS 36
725 ACIDOSIS 36
726 ACUTE PULMONARY OEDEMA 36
727 APPLICATION SITE REACTION 36
728 DISABILITY 36
729 EXTRA DOSE ADMINISTERED 36
730 GASTRIC ULCER 36
731 GOUT 36
732 HEAD DISCOMFORT 36
733 HEPATIC FUNCTION ABNORMAL 36
734 HERNIA 36
735 HYPOTONIA 36
736 IMPAIRED QUALITY OF LIFE 36
737 LIVER FUNCTION TEST INCREASED 36
738 MASS 36
739 PARKINSONISM 36
740 TOOTH ABSCESS 36
741 TOOTH LOSS 36
742 URINARY TRACT DISORDER 36
743 WHEELCHAIR USER 36
744 ARTERIOSCLEROSIS 35
745 BLOOD GLUCOSE ABNORMAL 35
746 BONE DENSITY DECREASED 35
747 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 35
748 DISSEMINATED INTRAVASCULAR COAGULATION 35
749 GALLBLADDER DISORDER 35
750 HYSTERECTOMY 35
751 INITIAL INSOMNIA 35
752 MALNUTRITION 35
753 MOOD SWINGS 35
754 OLIGURIA 35
755 PSYCHOLOGICAL TRAUMA 35
756 TORSADE DE POINTES 35
757 CANDIDA INFECTION 34
758 CARDIOVASCULAR DISORDER 34
759 DERMATITIS ACNEIFORM 34
760 ELECTROLYTE IMBALANCE 34
761 INCOHERENT 34
762 LARYNGITIS 34
763 MUSCLE ATROPHY 34
764 NEUROTOXICITY 34
765 NO THERAPEUTIC RESPONSE 34
766 PRESCRIBED OVERDOSE 34
767 SKIN ABRASION 34
768 ULCER 34
769 ACCIDENTAL EXPOSURE TO PRODUCT 33
770 ANTIPSYCHOTIC DRUG LEVEL INCREASED 33
771 ATRIAL FLUTTER 33
772 GASTROENTERITIS VIRAL 33
773 GRAND MAL CONVULSION 33
774 METASTASES TO LIVER 33
775 PROCEDURAL COMPLICATION 33
776 PROSTATIC SPECIFIC ANTIGEN INCREASED 33
777 SARS-COV-2 TEST POSITIVE 33
778 SINUS CONGESTION 33
779 URINE OUTPUT DECREASED 33
780 VASOPLEGIA SYNDROME 33
781 VITREOUS FLOATERS 33
782 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 33
783 BACK INJURY 32
784 BACTERAEMIA 32
785 BLOOD MAGNESIUM DECREASED 32
786 BLOOD PRESSURE SYSTOLIC DECREASED 32
787 CONTRAINDICATED PRODUCT ADMINISTERED 32
788 DEVICE RELATED INFECTION 32
789 ESCHERICHIA URINARY TRACT INFECTION 32
790 FACIAL PARALYSIS 32
791 INCREASED APPETITE 32
792 INTESTINAL ISCHAEMIA 32
793 ISCHAEMIC STROKE 32
794 JOINT DISLOCATION 32
795 LOWER GASTROINTESTINAL HAEMORRHAGE 32
796 OBSESSIVE-COMPULSIVE DISORDER 32
797 PAIN OF SKIN 32
798 SPINAL COMPRESSION FRACTURE 32
799 SPINAL PAIN 32
800 APPLICATION SITE WARMTH 31
801 BENIGN PROSTATIC HYPERPLASIA 31
802 CEREBRAL ATROPHY 31
803 CONCUSSION 31
804 DEVICE BREAKAGE 31
805 DIZZINESS POSTURAL 31
806 DRUG RESISTANCE 31
807 INSURANCE ISSUE 31
808 IRON DEFICIENCY ANAEMIA 31
809 LARYNGOSPASM 31
810 LUNG INFILTRATION 31
811 PANCREATITIS ACUTE 31
812 POLYURIA 31
813 PRODUCT AVAILABILITY ISSUE 31
814 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 31
815 RENAL FAILURE CHRONIC 31
816 SKIN LACERATION 31
817 TENDONITIS 31
818 APPLICATION SITE EXFOLIATION 30
819 APPLICATION SITE PAPULES 30
820 ARTERIOSCLEROSIS CORONARY ARTERY 30
821 BRAIN OEDEMA 30
822 BURSITIS 30
823 CHANGE OF BOWEL HABIT 30
824 CHOLESTASIS 30
825 COMA SCALE ABNORMAL 30
826 EYE HAEMORRHAGE 30
827 EYE INFLAMMATION 30
828 HAND FRACTURE 30
829 IMPAIRED DRIVING ABILITY 30
830 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 30
831 LACRIMATION INCREASED 30
832 MANIA 30
833 NYSTAGMUS 30
834 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 30
835 PHARYNGEAL OEDEMA 30
836 PLATELET COUNT INCREASED 30
837 POISONING 30
838 PRODUCT ADMINISTRATION INTERRUPTED 30
839 PRODUCT DISPENSING ERROR 30
840 PRODUCT PACKAGING QUANTITY ISSUE 30
841 PRODUCT PRESCRIBING ERROR 30
842 WEIGHT FLUCTUATION 30
843 BUNDLE BRANCH BLOCK LEFT 29
844 CARDIAC MURMUR 29
845 COVID-19 PNEUMONIA 29
846 CYST 29
847 ENURESIS 29
848 ERECTILE DYSFUNCTION 29
849 HEMIPLEGIA 29
850 IMMUNODEFICIENCY 29
851 MEDICATION RESIDUE PRESENT 29
852 MYASTHENIA GRAVIS 29
853 NASAL DRYNESS 29
854 PYELONEPHRITIS 29
855 SKIN FISSURES 29
856 STOMA SITE PAIN 29
857 THERAPEUTIC AGENT TOXICITY 29
858 TONGUE DISORDER 29
859 ANAESTHETIC COMPLICATION 28
860 CHOLECYSTECTOMY 28
861 COLON CANCER 28
862 EMPHYSEMA 28
863 FLUID OVERLOAD 28
864 GINGIVAL PAIN 28
865 INTENTIONAL DRUG MISUSE 28
866 INTENTIONAL SELF-INJURY 28
867 INTERSTITIAL LUNG DISEASE 28
868 LARGE INTESTINE PERFORATION 28
869 LIP DRY 28
870 MADAROSIS 28
871 NEOPLASM PROGRESSION 28
872 PELVIC PAIN 28
873 PHARYNGITIS 28
874 RASH MACULO-PAPULAR 28
875 THINKING ABNORMAL 28
876 APPLICATION SITE INFLAMMATION 27
877 BLOOD CREATININE DECREASED 27
878 CHOLECYSTITIS 27
879 EXTRASYSTOLES 27
880 HAEMORRHAGE INTRACRANIAL 27
881 HAIR COLOUR CHANGES 27
882 LUNG INFECTION 27
883 OSTEONECROSIS 27
884 OSTEONECROSIS OF JAW 27
885 PHARYNGEAL SWELLING 27
886 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 27
887 SINUS ARREST 27
888 SNEEZING 27
889 TENDERNESS 27
890 TOOTH INFECTION 27
891 TRANSFUSION 27
892 URINARY TRACT INFECTION BACTERIAL 27
893 APPLICATION SITE URTICARIA 26
894 ARTERIOSPASM CORONARY 26
895 BLOOD LACTATE DEHYDROGENASE INCREASED 26
896 BRADYKINESIA 26
897 COLD SWEAT 26
898 DERMATITIS 26
899 DERMATITIS ATOPIC 26
900 DEVICE LEAKAGE 26
901 DROOLING 26
902 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 26
903 FRUSTRATION TOLERANCE DECREASED 26
904 GASTROINTESTINAL PAIN 26
905 METASTASES TO BONE 26
906 NEPHROPATHY 26
907 NERVE INJURY 26
908 PHARMACEUTICAL PRODUCT COMPLAINT 26
909 PUPIL FIXED 26
910 SCRATCH 26
911 SEASONAL ALLERGY 26
912 SENSORY LOSS 26
913 TOXIC EPIDERMAL NECROLYSIS 26
914 APPENDICITIS 25
915 BONE MARROW FAILURE 25
916 BRAIN INJURY 25
917 COLITIS ISCHAEMIC 25
918 CORNEAL OEDEMA 25
919 DEVICE OCCLUSION 25
920 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 25
921 EOSINOPHIL COUNT DECREASED 25
922 EYELID PTOSIS 25
923 FAILURE TO THRIVE 25
924 GASTROINTESTINAL MOTILITY DISORDER 25
925 GRANULOCYTOPENIA 25
926 HEPATIC ENZYME ABNORMAL 25
927 HEPATITIS 25
928 HICCUPS 25
929 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 25
930 INCORRECT ROUTE OF DRUG ADMINISTRATION 25
931 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 25
932 INTERNAL HAEMORRHAGE 25
933 OCULAR DISCOMFORT 25
934 PERIPHERAL VASCULAR DISORDER 25
935 POLYDIPSIA 25
936 PREMATURE DELIVERY 25
937 RESPIRATORY ACIDOSIS 25
938 SCAB 25
939 SKIN HAEMORRHAGE 25
940 SOMNAMBULISM 25
941 WHITE BLOOD CELLS URINE POSITIVE 25
942 ACUTE CORONARY SYNDROME 24
943 ANGLE CLOSURE GLAUCOMA 24
944 ATRIOVENTRICULAR BLOCK SECOND DEGREE 24
945 BEHAVIOUR DISORDER 24
946 BLOOD SODIUM INCREASED 24
947 BLOOD TEST ABNORMAL 24
948 CARDIAC PACEMAKER INSERTION 24
949 CREPITATIONS 24
950 DECREASED ACTIVITY 24
951 DRUG WITHDRAWAL SYNDROME NEONATAL 24
952 DYSGRAPHIA 24
953 ESSENTIAL HYPERTENSION 24
954 EUPHORIC MOOD 24
955 EYE MOVEMENT DISORDER 24
956 GENERALISED OEDEMA 24
957 HYPERTHYROIDISM 24
958 HYPOALBUMINAEMIA 24
959 INJECTION SITE RASH 24
960 LIPASE INCREASED 24
961 MONOCYTE COUNT INCREASED 24
962 MULTIPLE FRACTURES 24
963 MUSCLE CONTRACTIONS INVOLUNTARY 24
964 PERITONITIS 24
965 PETECHIAE 24
966 PLANTAR FASCIITIS 24
967 POISONING DELIBERATE 24
968 PROCTALGIA 24
969 PRODUCT RESIDUE PRESENT 24
970 QUALITY OF LIFE DECREASED 24
971 RENAL PAIN 24
972 RESPIRATION ABNORMAL 24
973 SECRETION DISCHARGE 24
974 SKIN WARM 24
975 SPLENOMEGALY 24
976 STEVENS-JOHNSON SYNDROME 24
977 SYSTEMIC LUPUS ERYTHEMATOSUS 24
978 THERMAL BURN 24
979 TIBIA FRACTURE 24
980 TRISMUS 24
981 BLEPHAROSPASM 23
982 CULTURE URINE POSITIVE 23
983 DIABETIC KETOACIDOSIS 23
984 DIALYSIS 23
985 DRUG DOSE OMISSION BY DEVICE 23
986 FAECES SOFT 23
987 FREEZING PHENOMENON 23
988 HEPATOCELLULAR INJURY 23
989 HEPATOTOXICITY 23
990 IMPAIRED WORK ABILITY 23
991 INCORRECT PRODUCT ADMINISTRATION DURATION 23
992 INJECTION SITE EXTRAVASATION 23
993 INJECTION SITE URTICARIA 23
994 ISCHAEMIA 23
995 KNEE OPERATION 23
996 NERVE COMPRESSION 23
997 ODYNOPHAGIA 23
998 ORAL DISCOMFORT 23
999 PROTEIN TOTAL DECREASED 23